Delivery Order SPE2DB22D2006-SPE2DB24FV8MK
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $27,024.20 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $10,357.47 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $3,860.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit organization, a firm fixed price delivery order contract valued at $11,581.80 to provide RABAVERT rabies vaccine with diluents. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT RABIES VACC W-DILUENTS. The contract has a potential value of $1,930.30 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $38,606.00 delivery order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,606,199 units of RABAVERT Rabies Vaccine with diluents. This $1,544.24 contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used. This delivery order contract falls under a $999,999,999.00 indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with diluents. The $9,651.50 award has a performance period through March 5, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) with DLA valued up to...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8MKDelivery Order
The Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $38,606.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. This contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This contract is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.6k | 2/29/24 |